DANIEL K. SPIEGELMAN - 06 Jun 2024 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Director
Signature: By: Justin Hunter For: Daniel K. Spiegelman
Issuer symbol: MYGN
Transactions as of: 06 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 07 Jun 2024, 16:53:29 UTC
Previous filing: 04 Jun 2024
Next filing: 13 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MYGN	Common Stock						32,917	06 Jun 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

DANIEL K. SPIEGELMAN is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as a director of the Company, effective June 6, 2024, and therefore is no longer subject to Section 16 reporting